Home - About VASCERN - Structure and Governance - Working Groups - Rare Disease Working Groups - Medium Sized Arteries (MSA-WG)

Medium Sized Arteries (MSA-WG)

Introduction Diseases covered

Experts & Centers

Experts Centers

Clinical Decision Support Tools

Patient Pathways Do’s and Don’ts Clinical Practice Guidelines (CPGs) adopted Clinical Expert Consensus Statements Written Clinical Outcome Measures

Registry

Research

Clinical Trials/Observational Studies Research Publications

Training and Education

E-Learning Pills of Knowledge (PoK) Webinars

The MSA Working Group is built upon Multidisciplinary Centres of Excellence that are collaborating. The MSA-WG scope includes mainly Vascular Ehlers Danlos Syndrome. It will be enlarged to the other medium sized arteries diseases in the future.

The Medium-Sized Arteries (MSA WG) is one of the six Rare Disease Working Groups (RDWGs) of VASCERN that specialize in a particular type/group of rare vascular disease(s).

The MSA-WG is chaired by Dr. Michael Frank, from the French Reference Centre for Rare Vascular Diseases, CRMR Rare Vascular Diseases, CHU Paris IdF Ouest – HEGP Hôpital Européen Georges Pompidou, in Paris, France and Co-Chaired by Dr. Fransiska Malfait from the Center of Medical Genetics at Ghent University Hospital, in Ghent, Belgium.

The MSA-WG cooperates with the European Patient Advocacy Group (ePAG), which is represented by ePAG Co-Chair for MSA, Eva Collado (ANSEDH – Spanish National Patient Organization for Ehlers-Danlos)The MSA WG equally collaborates with the Ehlers-Danlos Society.